BIST10014.396,54 -0.43%Moderna'nın Kanser Aşısı Coşkusu Kar Satışlarına Yenik Düştü: 18 Milyar Dolarlık ErimeUSD/TRY48.2400 0.20%Moderna'nın Kişiselleştirilmiş mRNA Kumarı: Onkolojide Devrim mi, Borsa Balonu mu?EUR/TRY56.0526 0.30%Norveç'in Temmuz Petrol Üretimindeki %10 Düşüş, Avrupa Enerji Piyasalarını SarsıyorBTC/USD$72,682 6.25%XRP’in 2024 Seçim Sonrası En İyi Haftası ve Bitcoin Kısa Sıkışması Piyasayı SalladıGRAM ALTIN6.953,32 0.15%İngiliz Bankalarının Yeni Maliye Bakanına Sert Uyarısı ve Piyasa YansımalarıBRENT$93.55 2.11%Faiz Yükselmesiyle Borsa Kabarcıklarının Patlaması Tehlikesi: Piyasalar Nasıl Yanıt Verecek?Yapay Zeka Çağında İnsan Sermayesinin Direnci: Finansal Piyasalara YansımalarıBIST10014.396,54 -0.43%Moderna'nın Kanser Aşısı Coşkusu Kar Satışlarına Yenik Düştü: 18 Milyar Dolarlık ErimeUSD/TRY48.2400 0.20%Moderna'nın Kişiselleştirilmiş mRNA Kumarı: Onkolojide Devrim mi, Borsa Balonu mu?EUR/TRY56.0526 0.30%Norveç'in Temmuz Petrol Üretimindeki %10 Düşüş, Avrupa Enerji Piyasalarını SarsıyorBTC/USD$72,682 6.25%XRP’in 2024 Seçim Sonrası En İyi Haftası ve Bitcoin Kısa Sıkışması Piyasayı SalladıGRAM ALTIN6.953,32 0.15%İngiliz Bankalarının Yeni Maliye Bakanına Sert Uyarısı ve Piyasa YansımalarıBRENT$93.55 2.11%Faiz Yükselmesiyle Borsa Kabarcıklarının Patlaması Tehlikesi: Piyasalar Nasıl Yanıt Verecek?Yapay Zeka Çağında İnsan Sermayesinin Direnci: Finansal Piyasalara Yansımaları
Global Markets

Innovaccer's Data Revolution: Reaching $200M ARR in Health Tech

724FinanceEge Kaan
Key Highlights

Sağlık verisinin dağınık yapısına bir çözüm sunma iddiasıyla, **Innovaccer** CEO’su **Abhinav Shashank**, Disney ve NASA gibi büyük müşterileri geride

Innovaccer's Data Revolution: Reaching $200M ARR in Health Tech

Aiming to solve the fragmented landscape of health data, Innovaccer CEO Abhinav Shashank left behind marquee clients like Disney and NASA to execute a strategic pivot in 2016.

Diving into the Data Backbone

Innovaccer extracts information from hospitals' electronic health records (EHR) and insurance claim systems, unifying it into a single platform ready for AI tools and care coordination.

$200M ARR: A Financial Leap

  • $200 million ARR, up from $130 million last year, a 54% increase.
  • Total funding stands at $675 million, with a $275 million round closed last year.
  • Gartner placed Innovaccer ahead of Microsoft, Google, AWS and Salesforce in its inaugural Healthcare Technology Magic Quadrant for vision and execution.
  • Funding and Partnership Ecosystem

  • Strategic investors include B Capital, Danaher Ventures, Generation Investment Management, Kaiser Permanente, and Microsoft’s M12.
  • The firm now serves seven of the top ten U.S. health systems, covering 80 million patient records.
  • Operational Efficiency and Savings

  • U.S. healthcare spending is set to exceed $6 trillion this year, with $1.5 trillion attributed to administrative waste.
  • Innovaccer customers reported roughly $2.5 billion in savings last year, primarily from care coordination rather than new hardware.
  • Defne Aydın – Director of Geopolitical Risk and European Markets: “Standardizing health data infrastructure is a prerequisite for scalable AI‑driven care models, not only in the United States but globally. Innovaccer's growth signals a sustained capital inflow into data‑integration services, suggesting a long‑term investment trend. Europe faces similar data silos; this will likely trigger regulatory revisions and infrastructure spending across the region.”

    Related News & Analysis

    View All →

    Latest Market News

    All News →
    Ege Kaan

    Financial Analyst: Ege Kaan

    Wall Street ve ABD Makro Strateji Lideri. S&P 500 opsiyon piyasasındaki (VIX, Gamma Squeeze) fiyatlamaları ve kurumsal şirket karlarının (Earnings Season) Amerikan ekonomisindeki etkilerini anlatan uzman.

    Disclaimer: The investment information, comments, and recommendations contained herein are not within the scope of investment advisory. Investment advisory services are provided individually by authorized institutions, taking into account the risk and return preferences of individuals. The comments and recommendations contained herein are general in nature. These recommendations may not be suitable for your financial situation and your risk and return preferences. Therefore, making an investment decision based solely on the information contained herein may not produce results that meet your expectations.

    © 2026 724Finance - All Rights Reserved.Original Source: Fortune.com